Illuminare Biotechnologies
PrivateLast Round
Seed Round
Jun 4, 2026
Total Funding Raised
$2.37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Illuminare Biotechnologies is a biotechnology company that develops an intra-operative nerve visualization technology intended to reduce the risk of nerve damage.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illuminare Biotechnologies Comparables
Compare Illuminare Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trace Biosciences | 92% | |
| Alume Biosciences | 90% | |
| Dendrite Imaging, Inc. | 75% |
Illuminare Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 4, 2026 | ||||
| Series A | Aug 18, 2017 |
Illuminare Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thylacine Capital | Convertible Debt, Seed Round |
| Band of Angels | Seed Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 175% MoM.
- Jun 4, 2026
Raised $3.65M in a seed funding round.
Recent news
Latest coverage and updates
- hiresJul 14, 2026
Illuminare Bio hired Brian Longstreet as Chief Executive Officer on Jun 1st '26.
- hiresJul 14, 2026
Illuminare Bio hired Brian as Chief Executive Officer on Jun 1st '26.
Illuminare Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Illuminare Biotechnologies's valuation, stock price, and market status.
Is Illuminare Biotechnologies a public or private company?
Illuminare Biotechnologies is a private company.
What is the current stock price of Illuminare Biotechnologies?
Illuminare Biotechnologies is a private company with no public stock price. No recent secondary market data is available.
How much is Illuminare Biotechnologies worth (valuation)?
Valuation information for Illuminare Biotechnologies is not publicly available.
Can I buy Illuminare Biotechnologies stock?
Illuminare Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Illuminare Biotechnologies's last funding round?
Illuminare Biotechnologies's most recent funding round was Seed Round on June 4, 2026.
Who are the main investors in Illuminare Biotechnologies?
Key investors in Illuminare Biotechnologies include Thylacine Capital, Band of Angels.
Will Illuminare Biotechnologies IPO soon?
No public IPO plans have been announced for Illuminare Biotechnologies.
How can I track Illuminare Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Illuminare Biotechnologies's secondary market activity and sign up for updates.